A single-center experience: Liver biopsy results during a year
- PMID: 35783472
- PMCID: PMC9243760
- DOI: 10.14744/hf.2021.2021.0045
A single-center experience: Liver biopsy results during a year
Abstract
Background and aim: Liver biopsy is the gold standard method for the diagnosis and treatment of liver diseases. In this study, we aimed to evaluate the results of liver biopsies performed in a year in our clinic. In addition, we also aimed if these liver biopsies could reveal the etiology of liver disease in patients with elevations of transaminases or/and alkaline phosphatase levels or liver masses.
Materials and methods: Patients who had liver biopsies for persistently elevated transaminases or/and alkaline phosphatase levels, protocol biopsies after liver transplantation, or liver masses in our hepatology clinic between 2011 and 2012 were included in the study. Liver biopsy decisions were made by experts during the hepatology council. Liver biopsies were previously performed using classical percutaneous liver biopsy or ultrasonography-guided Sonocan® liver biopsy sets. The pathology results of liver biopsies and clinical data of the matching patients were obtained from the liver biopsy record archives and patient files, respectively.
Results: Totally, 479 liver biopsy results (male=252, 52.6%, mean age 49±14.5 years) were evaluated in the study. Of these patients, 432 (male=228) underwent percutaneous liver biopsy and 47 (male=24) underwent Sonocan® needle biopsy. The most common histopathologic diagnoses in the percutaneous liver biopsy group were chronic hepatitis B (n=127, 29.4%), normal histopathological findings (n=50, 11.6% and 32 of them were protocol biopsies after liver transplantation), and nonalcoholic steatohepatitis (NASH, n=41, 9.5%). The most common histopathologic diagnoses in the Sonocan® group were 25 liver metastasis out of 29 liver tumors (n=25, 53.2% of all) chronic hepatitis B (n=5, 10.6%), and NASH (n=3, 6.4%).
Conclusion: In this study, diversity in liver biopsy results indicates the importance of histopathological evaluation. The most prevalent pathology in the liver biopsies was chronic hepatitis B, which is the most common chronic liver disease in Turkey. The metastatic liver tumor was the most common among the liver masses.
Keywords: Cirrhosis; fatty liver; hepatitis; liver biopsy.
© Copyright 2022 by Hepatology Forum - Available online at www.hepatologyforum.org.
Conflict of interest statement
Conflict of Interest: The authors have no conflict of interest to declare.
Similar articles
-
The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.Obes Surg. 2004 Jan;14(1):54-9. doi: 10.1381/096089204772787293. Obes Surg. 2004. PMID: 14980034
-
Liver biopsies for chronic hepatitis C: should nonultrasound-guided biopsies be abandoned?Can J Gastroenterol. 2009 Jun;23(6):425-30. doi: 10.1155/2009/370651. Can J Gastroenterol. 2009. PMID: 19543573 Free PMC article.
-
Ultrasound-guided percutaneous liver biopsy in children. Five-year experience at a tertiary care center.Rev Gastroenterol Mex (Engl Ed). 2021 Mar 30:S0375-0906(21)00033-1. doi: 10.1016/j.rgmx.2021.01.006. Online ahead of print. Rev Gastroenterol Mex (Engl Ed). 2021. PMID: 33810931 English, Spanish.
-
Histological and Clinicopathological Evaluation of Liver Allograft Biopsy: An Initial Experience of Fifty Six Biopsies.J Clin Diagn Res. 2015 Nov;9(11):EC17-20. doi: 10.7860/JCDR/2015/13664.6812. Epub 2015 Nov 1. J Clin Diagn Res. 2015. PMID: 26673862 Free PMC article.
-
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.World J Gastroenterol. 2014 Jan 14;20(2):475-85. doi: 10.3748/wjg.v20.i2.475. World J Gastroenterol. 2014. PMID: 24574716 Free PMC article. Review.
Cited by
-
Intestinal Ultrasound: Advancing Towards Broader Adoption-Insights from a National Survey in Turkey.J Clin Med. 2025 Jul 8;14(14):4817. doi: 10.3390/jcm14144817. J Clin Med. 2025. PMID: 40725510 Free PMC article.
References
-
- Pinelo E, Presa J. Outpatient percutaneous liver biopsy: Still a good option. Eur J Intern Med. 2009;20(5):487–489. - PubMed
-
- Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344(7):495–500. - PubMed
-
- Tapper EB, Lok AS. Use of liver imaging and biopsy in clinical practice. N Engl J Med. 2017;377(8):756–768. - PubMed
-
- Rustagi T, Newton E, Kar P. Percutaneous liver biopsy. Trop Gastroenterol. 2010;31(3):199–212. - PubMed
-
- Mistik R, Balik I. Türkiye’de viral hepatitlerin epidemiyolojik analizi. In: Tekeli E, Balik İ, editors. Viral Hepatit. Ankara: Viral Hepatitle Savaşım Derneği; 2003. pp. 10–45.
LinkOut - more resources
Full Text Sources